Literature DB >> 27539782

Linkage to HIV care before and after the introduction of provider-initiated testing and counselling in six Rwandan health facilities.

Carmen B Franse1, Felix R Kayigamba2, Mirjam I Bakker1, Veronicah Mugisha3, Emmanuel Bagiruwigize4, Kirstin R Mitchell5, Anita Asiimwe6, Maarten F Schim van der Loeff7,8,9.   

Abstract

HIV testing and counselling forms the gateway to the HIV care and treatment continuum. Therefore, the World Health Organization recommends provider-initiated testing and counselling (PITC) in countries with a generalized HIV epidemic. Few studies have investigated linkage-to-HIV-care among out-patients after PITC. Our objective was to study timely linkage-to-HIV-care in six Rwandan health facilities (HFs) before and after the introduction of PITC in the out-patient departments (OPDs). Information from patients diagnosed with HIV was abstracted from voluntary counselling and testing, OPD and laboratory registers of six Rwandan HFs during three-month periods before (March-May 2009) and after (December 2009-February 2010) the introduction of PITC in the OPDs of these facilities. Information on patients' subsequent linkage-to-pre-antiretroviral therapy (ART) care and ART was abstracted from ART clinic registers of each HF. To triangulate the findings from HF routine, a survey was held among patients to assess reasons for non-enrolment. Of 635 patients with an HIV diagnosis, 232 (36.5%) enrolled at the ART clinic within 90 days of diagnosis. Enrolment among out-patients decreased after the introduction of PITC (adjusted odds ratio, 2.0; 95% confidence interval, 1.0-4.2; p = .051). Survey findings showed that retesting for HIV among patients already diagnosed and enrolled into care was not uncommon. Patients reported non-acceptance of disease status, stigma and problems with healthcare services as main barriers for enrolment. Timely linkage-to-HIV-care was suboptimal in this Rwandan study before and after the introduction of PITC; the introduction of PITC in the OPD may have had a negative impact on linkage-to-HIV-care. Healthier patients tested through PITC might be less ready to engage in HIV care. Fear of HIV stigma and mistrust of test results appear to be at the root of these problems.

Entities:  

Keywords:  Africa South of the Sahara; HIV; Rwanda; antiretroviral therapy; continuity of patient care; mass screening

Mesh:

Year:  2016        PMID: 27539782     DOI: 10.1080/09540121.2016.1220475

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  5 in total

1.  A Systematic Review of Linkage-to-Care and Antiretroviral Initiation Implementation Strategies in Low- and Middle-Income Countries Across Sub-Saharan Africa.

Authors:  Nneoma E Okonkwo; Alexander Blum; Nikita Viswasam; Elizabeth Hahn; Sofia Ryan; Gnilane Turpin; Carrie E Lyons; Stefan Baral; Bhakti Hansoti
Journal:  AIDS Behav       Date:  2022-01-28

2.  Experiences of Antiretroviral Therapy Initiation Among HIV-Positive Adults in Ethiopia: A Descriptive Phenomenological Design.

Authors:  Eden Tefera; Azwihangwisi Helen Mavhandu-Mudzusi
Journal:  HIV AIDS (Auckl)       Date:  2022-05-24

3.  UNAIDS 90-90-90 targets to end the AIDS epidemic by 2020 are not realistic: comment on "Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades".

Authors:  Luchuo Engelbert Bain; Clovis Nkoke; Jean Jacques N Noubiap
Journal:  BMJ Glob Health       Date:  2017-03-07

4.  Trends in knowledge of HIV status and efficiency of HIV testing services in sub-Saharan Africa, 2000-20: a modelling study using survey and HIV testing programme data.

Authors:  Katia Giguère; Jeffrey W Eaton; Kimberly Marsh; Leigh F Johnson; Cheryl C Johnson; Eboi Ehui; Andreas Jahn; Ian Wanyeki; Francisco Mbofana; Fidèle Bakiono; Mary Mahy; Mathieu Maheu-Giroux
Journal:  Lancet HIV       Date:  2021-03-02       Impact factor: 12.767

5.  Value stream mapping to characterize value and waste associated with accessing HIV care in South Africa.

Authors:  Christopher J Hoffmann; Minja Milovanovic; Anthony Kinghorn; Hae-Young Kim; Katlego Motlhaoleng; Neil A Martinson; Ebrahim Variava
Journal:  PLoS One       Date:  2018-07-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.